Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
33.55
-5.05 (-13.08%)
Mar 3, 2025, 4:00 PM EST - Market closed
PRAX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
Cash & Equivalents | 215.37 | 81.3 | 61.62 | 138.7 | 296.61 | Upgrade
|
Short-Term Investments | 177.2 | - | 38.87 | 137.21 | - | Upgrade
|
Cash & Short-Term Investments | 392.57 | 81.3 | 100.49 | 275.91 | 296.61 | Upgrade
|
Cash Growth | 382.86% | -19.10% | -63.58% | -6.98% | 561.85% | Upgrade
|
Prepaid Expenses | 11.81 | 3.58 | 10.35 | 10.9 | 5.12 | Upgrade
|
Restricted Cash | - | - | - | 0.6 | 0.6 | Upgrade
|
Total Current Assets | 404.37 | 84.88 | 110.84 | 287.41 | 302.33 | Upgrade
|
Property, Plant & Equipment | 1.36 | 2.65 | 3.87 | 4.87 | 0.84 | Upgrade
|
Long-Term Investments | 76.96 | - | - | - | - | Upgrade
|
Other Long-Term Assets | 0.42 | 0.42 | 0.42 | 0.47 | 0.02 | Upgrade
|
Total Assets | 483.11 | 87.95 | 115.13 | 292.75 | 303.18 | Upgrade
|
Accounts Payable | 12.53 | 5.82 | 14.67 | 10.78 | 4.09 | Upgrade
|
Accrued Expenses | 23.76 | 7.42 | 15.85 | 26.84 | 10.87 | Upgrade
|
Current Portion of Leases | 1.26 | 1.13 | 1.01 | 0.81 | 0.76 | Upgrade
|
Current Unearned Revenue | - | 1.39 | 2.82 | - | - | Upgrade
|
Total Current Liabilities | 37.55 | 15.75 | 34.35 | 38.43 | 15.72 | Upgrade
|
Long-Term Leases | 0.11 | 1.37 | 2.5 | 3.5 | - | Upgrade
|
Long-Term Unearned Revenue | - | 1.16 | 2.18 | - | - | Upgrade
|
Total Liabilities | 37.66 | 18.28 | 39.02 | 41.94 | 15.72 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
Additional Paid-In Capital | 1,282 | 723.58 | 606.92 | 567.6 | 437.01 | Upgrade
|
Retained Earnings | -836.74 | -653.92 | -530.64 | -316.62 | -149.55 | Upgrade
|
Comprehensive Income & Other | 0.65 | - | -0.17 | -0.18 | - | Upgrade
|
Total Common Equity | 445.45 | 69.67 | 76.11 | 250.81 | 287.46 | Upgrade
|
Shareholders' Equity | 445.45 | 69.67 | 76.11 | 250.81 | 287.46 | Upgrade
|
Total Liabilities & Equity | 483.11 | 87.95 | 115.13 | 292.75 | 303.18 | Upgrade
|
Total Debt | 1.37 | 2.5 | 3.5 | 4.31 | 0.76 | Upgrade
|
Net Cash (Debt) | 468.16 | 78.81 | 96.99 | 271.6 | 295.85 | Upgrade
|
Net Cash Growth | 494.07% | -18.75% | -64.29% | -8.20% | 582.36% | Upgrade
|
Net Cash Per Share | 26.14 | 11.95 | 31.56 | 95.96 | 495.82 | Upgrade
|
Filing Date Shares Outstanding | 20.16 | 13.24 | 3.49 | 3.03 | 2.57 | Upgrade
|
Total Common Shares Outstanding | 19.42 | 8.79 | 3.29 | 3.02 | 2.55 | Upgrade
|
Working Capital | 366.82 | 69.13 | 76.5 | 248.98 | 286.61 | Upgrade
|
Book Value Per Share | 22.93 | 7.92 | 23.12 | 83.05 | 112.67 | Upgrade
|
Tangible Book Value | 445.45 | 69.67 | 76.11 | 250.81 | 287.46 | Upgrade
|
Tangible Book Value Per Share | 22.93 | 7.92 | 23.12 | 83.05 | 112.67 | Upgrade
|
Machinery | 1.59 | 1.59 | 1.54 | 1.37 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.